Publications by authors named "Naomi Digiantonio"
Article Synopsis
- The text discusses the advancements in bispecific T cell-engaging therapies for cancer treatment, highlighting their unique ability to bind to both tumor-specific antigens and T cells to trigger an immune response.
- Several bispecific therapies, such as epcoritamab and glofitamab, have recently been approved for various types of blood cancers, including diffuse large B cell lymphoma and multiple myeloma.
- These therapies come with risks like cytokine release syndrome, necessitating careful monitoring and specific operational strategies that healthcare professionals, particularly pharmacists, must be aware of during administration.
Objective: To determine the impact of a pharmacy-led medication reconciliation program at a large community hospital. The magnitude of the benefit of pharmacy-led medication reconciliation was evaluated based on the number of medication-related discrepancies between nursing triage notes and medication histories performed by pharmacy technicians or students. Discrepancies identified by pharmacy personnel medication histories that required pharmacist intervention on physician admission orders were further classified based on expected clinical impact if the error were to be propagated throughout hospitalization.
View Article and Find Full Text PDF